Resources
4
Apr,
2022
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals Deals mark an important...
Read More
1
Feb,
2022
AMR Action Fund Appoints Scientific Advisory Board
This move brings the Fund, launched one year ago, one step closer to delivering 2 to 4 new antibiotics to...
12
Oct,
2021
Antibiotic resistance in the patient with cancer
The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.
21
Sep,
2021
The AMR Action Fund Appoints Bill Burns as Board Chair
This move brings the Fund, launched one year ago, one step closer to delivering 2 to 4 new antibiotics to...
15
Jul,
2021
The AMR Action Fund Appoints John H. Rex, MD as Chair of its Sc...
This move brings the Fund, launched one year ago, one step closer to delivering 2 to 4 new antibiotics to...
